SEC Form 4 · accession 0001104659-17-024510

PRA Health Sciences, Inc. · PRAH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive VP & CFO

Period of report

Apr 17, 2017

Accepted (ET)

Apr 19, 2017 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001613859

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 17, 2017	M	124,472	$2.94	A	124,472	D
Common Stock^F2	Apr 17, 2017	S	124,472	$63.59	D	0	D
Common Stock	Apr 17, 2017	M	71,921	$11.73	A	71,921	D
Common Stock^F2	Apr 17, 2017	S	71,921	$63.59	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$2.94	Apr 17, 2017	M	108,129	D	—	Dec 21, 2017	Common Stock	108,129	0	D
Stock Option (Right to Buy)^F3	$2.94	Apr 17, 2017	M	16,343	D	—	Apr 2, 2022	Common Stock	16,343	0	D
Stock Option (Right to Buy)^F4	$11.73	Apr 17, 2017	M	71,921	D	—	Dec 20, 2023	Common Stock	71,921	126,340	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.34 to $63.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3The options vested on September 23, 2013.
F439,652 of the options vested on September 23, 2014; 32,269 of the options vested on September 23, 2015.